Basic residues in the matrix domain and multimerization target murine leukemia virus gag to the virological synapse

Journal of Virology

Volumn 87, Issue 12, 2013, Pages 7113-7126

  Li, Fei ^a   Jin, Jing ^a   Herrmann, Christin ^a   Mothes, Walther ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLSERINE; PROTEIN KINASE FYN; PROTEIN TYROSINE KINASE; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CONTACT; CONTROLLED STUDY; MATRIX DOMAIN; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN MULTIMERIZATION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION;

ANIMALS; CELL LINE; GENE PRODUCTS, GAG; HEK293 CELLS; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; PROTEIN MULTIMERIZATION; VIRAL ENVELOPE PROTEINS; VIRUS ASSEMBLY;

MURINE LEUKEMIA VIRUS;

EID: 84878576356     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03263-12     Document Type: Article

References (71)

1. Morita E, Sundquist WI. 2004. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20:395-425.
2. Jin J, Sherer NM, Heidecker G, Derse D, Mothes W. 2009. Assembly of the murine leukemia virus is directed towards sites of cell-cell contact. PLoS Biol. 7:e1000163. doi:10.1371/journal.pbio.1000163.
3. Jouvenet N, Neil SJ, Bess C, Johnson MC, Virgen CA, Simon SM, Bieniasz PD. 2006. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4:e435. doi:10.1371/journal.pbio.0040435.
4. Welsch S, Keppler OT, Habermann A, Allespach I, Krijnse-Locker J, Krausslich HG. 2007. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3:e36. doi:10.1371 /journal.ppat.0030036.
5. Murray PS, Li Z, Wang J, Tang CL, Honig B, Murray D. 2005. Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure 13: 1521-1531.
6. Spearman P, Wang JJ, Vander Heyden N, Ratner L. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242.
7. Zhou W, Parent LJ, Wills JW, Resh MD. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.
8. Zhou W, Resh MD. 1996. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70:8540-8548.
9. Freed EO, Orenstein JM, Bucklerwhite AJ, Martin MA. 1994. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:5311-5320.
10. Granowitz C, Goff SP. 1994. Substitution mutations affecting a small region of the Moloney murine leukemia virus MA Gag protein block assembly and release of virion particles. Virology 205:336-344.
11. Hamard-Peron E, Juillard F, Saad JS, Roy C, Roingeard P, Summers MF, Darlix JL, Picart C, Muriaux D. 2010. Targeting of murine leukemia virus Gag to the plasma membrane is mediated by PI(4,5)P-2/PS and a polybasic region in the matrix. J. Virol. 84:503-515.
12. Hermida-Matsumoto L, Resh MD. 2000. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J. Virol. 74:8670-8679.
13. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. 2004. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 gag targeting to the plasma membrane. Mol. Biol. Cell 15:122a-123a.
14. Ono A, Freed EO. 1999. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73:4136-4144.
15. Soneoka Y, Kingsman SM, Kingsman AJ. 1997. Mutagenesis analysis of the murine leukemia virus matrix protein: Identification of regions important for membrane localization and intracellular transport. J. Virol. 71:5549-5559.
16. Resh MD. 1999. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451:1-16.
17. McLaughlin S, Aderem A. 1995. The myristoyl-electrostatic switch-a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20:272-276.
18. Murray D, Matsumoto LH, Buser CA, Tsang J, Sigal CT, Ben-Tal N, Honig B, Resh MD, McLaughlin S. 1998. Electrostatics and the membrane association of Src: theory and experiment. Biochemistry 37:2145-2159.
19. Reuther GW, Buss JE, Quilliam LA, Clark GJ, Der CJ. 2000. Analysis of function and regulation of proteins that mediate signal transduction by use of lipid-modified plasma membrane-targeting sequences. Methods Enzymol. 327:331-350.
20. Sigal CT, Zhou WJ, Buser CA, Mclaughlin S, Resh MD. 1994. Aminoterminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids. Proc. Natl. Acad. Sci. U. S. A. 91:12253-12257.
21. Di Paolo G, De Camilli P. 2006. Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651-657.
22. Leventis PA, Grinstein S. 2010. The distribution and function of phosphatidylserine in cellular membranes. Annu. Rev. Biophys. 39:407-427.
23. Heo WD, Inoue T, Park WS, Kim ML, Park BO, Wandless TJ, Meyer T. 2006. PI(3,4,5)P-3 and PI(4,5)P-2 lipids target proteins with polybasic clusters to the plasma membrane. Science 314:1458-1461.
24. McLaughlin S, Murray D. 2005. Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438:605-611.
25. Yeung T, Gilbert GE, Shi J, Silvius J, Kapus A, Grinstein S. 2008. Membrane phosphatidylserine regulates surface charge and protein localization. Science 319:210-213.
26. Hamard-Peron E, Muriaux D. 2011. Retroviral matrix and lipids, the intimate interaction. Retrovirology 8:15.
27. Ono A. 2009. HIV-1 assembly at the plasma membrane: Gag trafficking and localization. Future Virol. 4:241-257.
28. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, Wenk MR. 2008. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82:11228-11238.
29. Chen K, Bachtair I, Piszczek G, Bouamr F, Carter C, Tjandra N. 2008. Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry 47:1928-1937.
30. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. 2004. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 101:14889-14894.
31. Saad JS, Ablan SD, Ghanam RH, Kim A, Andrews K, Nagashima K, Soheilian F, Freed EO, Summers MF. 2008. Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J. Mol. Biol. 382:434-447.
32. Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF. 2006. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U. S. A. 103:11364-11369.
33. Stansell E, Apkarian R, Haubova S, Diehl WE, Tytler EM, Hunter E. 2007. Basic residues in the Mason-Pfizer monkey virus Gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J. Virol. 81:8977-8988.
34. Fernandes F, Chen K, Ehrlich LS, Jin J, Chen MH, Medina GN, Symons M, Montelaro R, Donaldson J, Tjandra N, Carter CA. 2011. Phosphoinositides direct equine infectious anemia virus Gag trafficking and release. Traffic 12:438-451.
35. Ding LM, Derdowski A, Wang JJ, Spearman P. 2003. Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts. J. Virol. 77:1916-1926.
36. Halwani R, Khorchid A, Cen S, Kleiman L. 2003. Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1. J. Virol. 77:3973-3984.
37. Lindwasser OW, Resh MD. 2001. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75:7913-7924.
38. Llewellyn GN, Hogue IB, Grover JR, Ono A. 2010. Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells. PLoS Pathog. 6:e1001167. doi:10.1371/journal .ppat.1001167.
39. Ono A, Freed EO. 2001. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U. S. A. 98:13925-13930.
40. Ehrlich LS, Agresta BE, Carter CA. 1992. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:4874-4883.
41. Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP. 1997. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278:849-853.
42. Burniston MT, Cimarelli A, Colgan J, Curtis SP, Luban J. 1999. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein. J. Virol. 73:8527-8540.
43. Dawson L, Yu XF. 1998. The role of nucleocapsid of HIV-1 in virus assembly. Virology 251:141-157.
44. Lapadat-Tapolsky M, De Rocquigny H, Van Gent D, Roques B, Plasterk R, Darlix JL. 1993. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21:831-839.
45. Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI. 1996. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. U. S. A. 93:3099-3104.
46. Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF. 2004. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. U. S. A. 101:517-522.
47. Alfadhli A, Barklis RL, Barklis E. 2009. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology 387:466-472.
48. Alfadhli A, Huseby D, Kapit E, Colman D, Barklis E. 2007. Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. J. Virol. 81:1472-1478.
49. Hope TJ. 2007. Bridging efficient viral infection. Nat. Cell Biol. 9:243-244.
50. Hubner W, McNerney GP, Chen P, Dale BM, Gordon RE, Chuang FY, Li XD, Asmuth DM, Huser T, Chen BK. 2009. Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science 323:1743-1747.
51. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M, Bangham CR. 2003. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:1713-1716.
52. Johnson DC, Huber MT. 2002. Directed egress of animal viruses promotes cell-to-cell spread. J. Virol. 76:1-8.
53. Jolly C, Sattentau QJ. 2004. Retroviral spread by induction of virological synapses. Traffic 5:643-650.
54. McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ. 2003. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300:1295-1297.
55. Mothes W, Sherer NM, Jin J, Zhong P. 2010. Virus cell-to-cell transmission. J. Virol. 84:8360-8368.
56. Phillips DM. 1994. The role of cell-to-cell transmission in HIV infection. AIDS 8:719-731.
57. Rudnicka D, Feldman J, Porrot F, Wietgrefe S, Guadagnini S, Prevost MC, Estaquier J, Haase AT, Sol-Foulon N, Schwartz O. 2009. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J. Virol. 83:6234-6246.
58. Sattentau Q. 2008. Avoiding the void: cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 6:815-826.
59. Jin J, Li F, Mothes W. 2011. Viral determinants of polarized assembly for the murine leukemia virus. J. Virol. 85:7672-7682.
60. Sewald X, Gonzalez DG, Haberman AM, Mothes W. 2012. In vivo imaging of virological synapses. Nat. Commun. 3:1320.
61. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, Mothes W. 2007. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell Biol. 9:310-315.
62. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, Cicchetti G, Allen PG, Pypaert M, Cunningham JM, Mothes W. 2003. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4:785-801.
63. Dormann D, Weijer G, Dowler S, Weijer CJ. 2004. In vivo analysis of 3-phosphoinositide dynamics during Dictyostelium phagocytosis and chemotaxis. J. Cell Sci. 117:6497-6509.
64. Zavorotinskaya T, Qian Z, Franks J, Albritton LM. 2004. A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J. Virol. 78:473-481.
65. Maag D, Maxwell MJ, Hardesty DA, Boucher KL, Choudhari N, Hanno AG, Ma JF, Snowman AS, Pietropaoli JW, Xu RS, Storm PB, Saiardi A, Snyder SH, Resnick AC. 2011. Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proc. Natl. Acad. Sci. U. S. A. 108:1391-1396.
66. Accola MA, Strack B, Gottlinger HG. 2000. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74:5395-5402.
67. Lee PP, Linial ML. 1994. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J. Virol. 68:6644-6654.
68. Wang CT, Zhang Y, McDermott J, Barklis E. 1993. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67:7067-7076.
69. Llewellyn GN, Grover JR, Olety B, Ono A. 2013. HIV-1 Gag associates with specific uropod-directed microdomains in a manner dependent on its MA highly basic region. J. Virol. 87:6441-6454.
70. Inlora J, Chukkapalli V, Derse D, Ono A. 2011. Gag localization and virus-like particle release mediated by the matrix domain of human Tlymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-( 4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag. J. Virol. 85:3802-3810.
71. Gregory DA, Lyddon TD, Johnson MC. 2012. Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions. J. Virol. 87:1518-1527.